Salvatore Buffardi
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Correction to: Predictive and prognostic role of volumetric analyses and lymphoma dissemination in pediatric HL: a prospective, multicenter, cohort study.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 11, 2025
Immunoprofiling, sex- and age-related determinants of treatment response in paediatric, adolescent and young adult Hodgkin lymphoma.
Journal: British journal of haematology
Published: November 05, 2025
Predictive and prognostic role of volumetric analyses and lymphoma dissemination in pediatric HL: a prospective, multicenter, cohort study.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 11, 2025
Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: January 02, 2025
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.
Journal: Blood
Published: September 09, 2022
Prospective Evaluation of Different Methods for Volumetric Analysis on [18F]FDG PET/CT in Pediatric Hodgkin Lymphoma.
Journal: Journal of clinical medicine
Published: August 30, 2022
Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma.
Journal: International journal of molecular sciences
Published: July 28, 2022
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia.
Journal: Frontiers in oncology
Published: April 05, 2022
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Journal: Pediatric blood & cancer
Published: December 13, 2021
Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma.
Journal: Pediatric blood & cancer
Published: October 01, 2021
Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience.
Journal: Diagnostics (Basel, Switzerland)
Published: August 04, 2021
Last Updated: 09/26/2026